Kimberly Wiltrout, MD
Neurologist, Department of Neurology
Instructor of Neurology, Harvard Medical School
Image
NPI
1073994216
Locations
Kimberly Wiltrout, MD
Neurologist, Department of Neurology
Instructor of Neurology, Harvard Medical School
Medical Services
Languages
English
Education
Undergraduate School
Franklin & Marshall College
2011
Lancaster
PA
Medical School
University of Rochester School of Medicine and Dentistry
2015
Rochester
NY
Residency
Pediatrics
St. Louis Children's Hospital/Washington University in St. Louis
2017
St. Louis
MO
Residency
Pediatric Neurology
St. Louis Children's Hospital/Washington University in St. Louis
2020
St. Louis
MO
Fellowship
Epilepsy
St. Louis Children's Hospital/Washington University in St. Louis
2021
St. Louis
MO
Fellowship
Neurogenetics/Epilepsy Genetics
Boston Children's Hospital
2022
Boston
MA
Certifications
American Board of Psychiatry and Neurology (Child and Adolescent Neurology)
American Board of Psychiatry and Neurology (Epilepsy)
Professional History
Dr. Wiltrout is a neurologist and epileptologist at Boston Children’s Hospital with board certification in neurology with special qualification in child neurology. Dr. Wiltrout obtained her Bachelor of Arts in neuroscience at Franklin & Marshall College and her MD degree at the University of Rochester. She completed her child neurology residency and epilepsy fellowship at Washington University in St. Louis before completing a fellowship in the Epilepsy Genetics Program at Boston Children’s Hospital. In addition to seeing patients in the Epilepsy Genetics Program, she has ongoing clinical research projects with a focus on SYNGAP1 Related Disorder.
Publications
Expanding the phenotype and genotype spectrum of TAOK1 neurodevelopmental disorder and delineating TAOK2 neurodevelopmental disorder. View Abstract
CIC-Related Neurodevelopmental Disorder: A Review of the Literature and an Expansion of Genotype and Phenotype. View Abstract
The spectrum of movement disorders in young children with ARX-related epilepsy-dyskinesia syndrome. View Abstract
Consensus reporting guidelines to address gaps in descriptions of ultra-rare genetic conditions. View Abstract
Comprehensive phenotypes of patients with SYNGAP1-related disorder reveals high rates of epilepsy and autism. View Abstract
Evaluation of the feasibility, diagnostic yield, and clinical utility of rapid genome sequencing in infantile epilepsy (Gene-STEPS): an international, multicentre, pilot cohort study. View Abstract
Utility of Exome Sequencing for Diagnosis in Unexplained Pediatric-Onset Epilepsy. View Abstract
Variants in DOCK3 cause developmental delay and hypotonia. View Abstract
Locations